About Us‎ > ‎Latest Medication News‎ > ‎

Product Recall: Ranitidine 150 mg & 300 mg Tablets

posted Nov 3, 2019, 10:20 PM by Muhammad Fikree Ahmad   [ updated Nov 3, 2019, 10:20 PM by Ho Ai Wui ]
29th October 2019 (Circular No. SP PPUM:   451/2019): 

Product Name


Pharmaniaga Ranitidine

Active Ingredient





150 mg & 300 mg

Dosage Form





Pharmaniaga Manufacturing Berhad

Product Registration Number




Batch Number


All batches manufactured within October 2016 to September 2019

Please be informed that Pharmaniaga Manufacturing Berhad, the distributor of this product, has been given notice of product recall due to the adulterated active ingredient. The use of this product should be stopped immediately.

Therefore, all clinical areas keeping the stocks for this product are required segregate the affected stocks and send to Inpatient Pharmacy for disposal purpose. Doctors are advised to prescribe Famotidine 20 mg Tablet as alternative.